FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:1836-1847 November 6, 2003 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Despite advances in emergency medical systems and in techniques of resuscitation, sudden death from cardiac arrest remains a major public health problem. Most persons who have an out-of-hospital cardiac arrest do not survive.^1,2 Those who are resuscitated may have severe, long-term cognitive impairment and motor impairment due to delays before a stable rhythm could be restored. In the 1970s, motivated by the death of a colleague, Drs. Michel Mirowski and Morton Mower, and their colleagues, developed the concept of an implantable device that could automatically monitor and analyze cardiac rhythm and deliver defibrillating shocks when it detected ventricular fibrillation.^3,4 After . . . [Full Text of this Article]

Components and Function

Detection of Arrhythmia

Other Functions of Implantable Defibrillators

Clinical Trials

Secondary-Prevention Trials

Defibrillator Therapy plus Drug Therapy in Secondary Prevention

Primary-Prevention Trials

Cardiac Resynchronization and the Implantable Cardioverter–Defibrillator

Complications

Follow-up

Factors Affecting Use

Summary

Source Information

From the Electrophysiology Laboratory, Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville.

Address reprint requests to Dr. DiMarco at the Cardiovascular Division, Department of Medicine, University of Virginia Health System, P.O. Box 800158, Charlottesville, VA 22908-0158, or at jdimarco@virginia.edu.

Related Letters:

Implantable Cardioverter–Defibrillators and Complications
Sinclair C. T., Marymount J. H. III, Rozner M. A., DiMarco J. P.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:734-735, Feb 12, 2004. Correspondence

This article has been cited by other articles:

• Sherazi, S., Daubert, J. P., Block, R. C., Jeevanantham, V., Abdel-Gadir, K., DiSalle, M. R., Haley, J. M., Shah, A. H. (2008). Physicians' Preferences and Attitudes About End-of-Life Care in Patients With an Implantable Cardioverter-Defibrillator. Mayo Clin Proc. 83: 1139-1141 [Abstract] [Full Text]  
• Dorian, P., Al-Khalidi, H. R., Hohnloser, S. H., Brum, J. M., Dunnmon, P. M., Pratt, C. M., Holroyde, M. J., Kowey, P., on behalf of the SHIELD (SHock Inhibition Evaluati, (2008). Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial. J Am Coll Cardiol 52: 1076-1083 [Abstract] [Full Text]  
• Nielsen, J. C., Kottkamp, H., Zabel, M., Aliot, E., Kreutzer, U., Bauer, A., Schuchert, A., Neuser, H., Schumacher, B., Schmidinger, H., Stix, G., Clementy, J., Danilovic, D., Hindricks, G. (2008). Automatic home monitoring of implantable cardioverter defibrillators. Europace 10: 729-735 [Abstract] [Full Text]  
• Estes, N.A. M. III (2007). Ablation after ICD Implantation -- Bridging the Gap between Promise and Practice. NEJM 357: 2717-2719 [Full Text]  
• Liu, C.-P., Ho, Y.-L., Lin, Y.-H., Liu, Y.-B., Chang, W.-T., Huang, C.-H., Chen, W.-J. (2007). Management of patients with implantable cardioverter defibrillators at emergency departments. Emerg. Med. J. 24: 106-109 [Abstract] [Full Text]  
• Gehi, A. K., Mehta, D., Gomes, J. A. (2006). Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock. JAMA 296: 2839-2847 [Abstract] [Full Text]  
• Hohnloser, S. H., Al-Khalidi, H. R., Pratt, C. M., Brum, J. M., Tatla, D. S., Tchou, P., Dorian, P., on behalf of the SHock Inhibition Evaluation with, (2006). Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 27: 3027-3032 [Abstract] [Full Text]  
• Seo, D., Ginsburg, G. S., Goldschmidt-Clermont, P. J. (2006). Gene Expression Analysis of Cardiovascular Diseases: Novel Insights Into Biology and Clinical Applications. J Am Coll Cardiol 48: 227-235 [Abstract] [Full Text]  
• Stecker, E. C., Vickers, C., Waltz, J., Socoteanu, C., John, B. T., Mariani, R., McAnulty, J. H., Gunson, K., Jui, J., Chugh, S. S. (2006). Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction: Two-Year Findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47: 1161-1166 [Abstract] [Full Text]  
• Goldberger, Z., Lampert, R. (2006). Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies. JAMA 295: 809-818 [Abstract] [Full Text]  
• Zhang, X., Ramachandra, I., Liu, Z., Muneer, B., Pogwizd, S. M., He, B. (2005). Noninvasive three-dimensional electrocardiographic imaging of ventricular activation sequence. Am. J. Physiol. Heart Circ. Physiol. 289: H2724-H2732 [Abstract] [Full Text]  
• Sears, S. F., Saia Lewis, T., Kuhl, E. A., Conti, J. B. (2005). Predictors of Quality of Life in Patients With Implantable Cardioverter Defibrillators. Psychosomatics 46: 451-457 [Abstract] [Full Text]  
• Kadish, A., Mehra, M. (2005). Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy. Circulation 111: 3327-3335 [Full Text]  
• Schulman, J. K., Muskin, P. R., Shapiro, P. A. (2005). Psychiatry and Cardiovascular Disease. Focus 3: 208-224 [Abstract] [Full Text]  
• Hunter, T. B., Taljanovic, M. S., Tsau, P. H., Berger, W. G., Standen, J. R. (2004). Medical Devices of the Chest. RadioGraphics 24: 1725-1746 [Abstract] [Full Text]  
• Boriani, G., Maron, B. J., Shen, W.-K., Spirito, P. (2004). Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient?. Circulation 110: e438-e442 [Full Text]  
• Voigt, A., Ezzeddine, R., Barrington, W., Obiaha-Ngwu, O., Ganz, L. I., London, B., Saba, S. (2004). Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 44: 855-858 [Abstract] [Full Text]  
• Josephson, M., Wellens, H. J.J. (2004). Implantable Defibrillators and Sudden Cardiac Death. Circulation 109: 2685-2691 [Full Text]  
• Sinclair, C. T., Marymount, J. H. III, Rozner, M. A., DiMarco, J. P. (2004). Implantable Cardioverter-Defibrillators and Complications. NEJM 350: 734-735 [Full Text]